<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01040416</url>
  </required_header>
  <id_info>
    <org_study_id>CMC IRB No. 2008081</org_study_id>
    <secondary_id>U1111-1112-9849</secondary_id>
    <nct_id>NCT01040416</nct_id>
  </id_info>
  <brief_title>Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass</brief_title>
  <acronym>BleedingMU</acronym>
  <official_title>Endoscopic Therapy for Actively Bleeding Marginal Ulcers: Our Experience After 7,020 Roux-en-Y Gastric Bypass Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Francisco</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to identify the incidence rate; describe the risk factors,
      clinical presentation, and endoscopic treatment; assess the morbidity, mortality, and overall
      performance of the management of patients with actively bleeding marginal ulcers after
      Roux-en-Y gastric bypass (RYGB) surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Marginal ulceration &quot;MU&quot;, which presents as an ulcer at the margins of the gastrojejunostomy
      on the jejunal side, is a common late complication after RYGB. Its incidence after RYGB
      ranges from as low as 0.6 to as high as 16%. In our hands with the laparoscopic hand-sewn
      technique for the GJ, the incidence is 1.4%. The presence of specific technical factors -
      staple-line dehiscence or gastro-gastric fistula, enlarged pouch, foreign material and local
      ischemia - and environmental factors - tobacco, NSAID´s, alcohol consumption, and H pylori
      infection among others - have been associated with marginal ulceration however the exact
      etiopathogenesis has not been completely elucidated.

      Similar to peptic ulcer disease (PUD), most marginal ulcers respond to medical therapy,
      specifically sucralfate and acid-lowering medication. In contrast, complicated marginal
      ulcers - perforation, bleeding, or chronicity (obstruction, penetration, and intractability)-
      warrants operative intervention.

      Early presentation of hemorrhage after RYGB is mostly related to staple-line failure and may
      result in either GI or intraabdominal hemorrhage. When indicated, operative interventions
      consist of either endoscopic therapy, re-operation, or both. In contrast, late presentation
      of gastrointestinal hemorrhage after RYGB is mostly secondary to a bleeding marginal ulcer
      however complicated peptic ulcer disease can present in the excluded stomach and duodenum as
      well.

      Most literature available for the management of GI hemorrhage after RYGB is for the early
      presentation of hemorrhage secondary to staple-line failure. Hence, options for endoscopic
      hemostatic therapy described in this scenario are I) injection therapy, II) coagulation
      therapy, III) endoscopic clipping, and IV) a combined modality (for example injection &amp;
      coagulation or injection and clipping).

      The feasibility, reliability, reproducibility, efficacy, validity and safety of the
      endoscopic hemostatic therapy for acutely bleeding peptic ulcers has been well documented.
      Multiple risk-stratification tools for upper-GI hemorrhage have also been developed such as
      the Blatchford, clinical and complete Rockall scores, and the Forrest classification.
      Moreover, pre and post endoscopic schemes of PPI´s therapy in patients with bleeding peptic
      ulcers is effective and cost-saving. However, All of them have not been validated in the
      obese population status post RYGB complicated with a bleeding marginal ulcer.

      Summarizing, there is scant information about the management of late complications after
      gastric bypass especially after the widespread adoption of the laparoscopic approach and the
      modern anatomical construct of Roux-en-Y Gastric Bypass surgery. We formally analyze the
      management efficacy of patients with actively bleeding marginal ulcers after Roux-en-Y
      gastric bypass (RYGB) surgery.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">December 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Morbidity and mortality, overall</measure>
    <time_frame>throughout follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>re-bleeding, gastrointestinal hemorrhage secondary to marginal ulceration</measure>
    <time_frame>throughout follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>marginal ulcer recurrence</measure>
    <time_frame>at last follow-up</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptom resolution, marginal ulcer</measure>
    <time_frame>at last follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>consumption of blood products</measure>
    <time_frame>during bleeding-related hospitalization</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>weight loss expressed as Body Mass Index and Percentage excess weight loss</measure>
    <time_frame>at the lowest point and yearly intervals</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">45</enrollment>
  <condition>Bleeding Marginal Ulcer</condition>
  <arm_group>
    <arm_group_label>Bleeding marginal ulcer after RYGB</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with actively bleeding marginal ulcers after Roux-en-Y gastric bypass (RYGB)
        surgery.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients status post laparoscopic RYGB surgery with active gastrointestinal hemorrhage
             secondary to marginal ulcer

        Exclusion Criteria:

          -  bleeding marginal ulcers after other bariatric procedures

          -  staple-line bleeding after RYGB

          -  iron-deficiency anemia (chronic) secondary to non-actively bleeding marginal ulcer
             after RYGB

          -  other sources of GI bleeding different from marginal ulcer such as from staple-lines,
             complicated PUD, and other surgical and medical causes of GI hemorrhage

          -  missing records and/or unreachable patients with scant information for analysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francisco M Tercero, MD</last_name>
    <role>Study Director</role>
    <affiliation>Research Associate, University of California San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kelvin D Higa, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Surgery, University of California San Francisco</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSF Fresno Center for Medical Education and Research</name>
      <address>
        <city>Fresno</city>
        <state>California</state>
        <zip>93701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.fresno.ucsf.edu/surgery</url>
    <description>&quot;Click here for more information about the department sponsor´s web site&quot;</description>
  </link>
  <reference>
    <citation>Higa KD, Boone KB, Ho T, Davies OG. Laparoscopic Roux-en-Y gastric bypass for morbid obesity: technique and preliminary results of our first 400 patients. Arch Surg. 2000 Sep;135(9):1029-33; discussion 1033-4.</citation>
    <PMID>10982506</PMID>
  </reference>
  <reference>
    <citation>Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA. 2004 Jun 16;291(23):2847-50.</citation>
    <PMID>15199035</PMID>
  </reference>
  <reference>
    <citation>McTigue KM, Harris R, Hemphill B, Lux L, Sutton S, Bunton AJ, Lohr KN. Screening and interventions for obesity in adults: summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2003 Dec 2;139(11):933-49.</citation>
    <PMID>14644897</PMID>
  </reference>
  <reference>
    <citation>Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004 Oct 13;292(14):1724-37. Review. Erratum in: JAMA. 2005 Apr 13;293(14):1728.</citation>
    <PMID>15479938</PMID>
  </reference>
  <reference>
    <citation>Christou NV, Sampalis JS, Liberman M, Look D, Auger S, McLean AP, MacLean LD. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004 Sep;240(3):416-23; discussion 423-4.</citation>
    <PMID>15319713</PMID>
  </reference>
  <reference>
    <citation>Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007 Aug 23;357(8):753-61.</citation>
    <PMID>17715409</PMID>
  </reference>
  <reference>
    <citation>Sjöström L, Narbro K, Sjöström CD, Karason K, Larsson B, Wedel H, Lystig T, Sullivan M, Bouchard C, Carlsson B, Bengtsson C, Dahlgren S, Gummesson A, Jacobson P, Karlsson J, Lindroos AK, Lönroth H, Näslund I, Olbers T, Stenlöf K, Torgerson J, Agren G, Carlsson LM; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007 Aug 23;357(8):741-52.</citation>
    <PMID>17715408</PMID>
  </reference>
  <reference>
    <citation>Cremieux PY, Buchwald H, Shikora SA, Ghosh A, Yang HE, Buessing M. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008 Sep;14(9):589-96.</citation>
    <PMID>18778174</PMID>
  </reference>
  <reference>
    <citation>Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA. 2005 Oct 19;294(15):1909-17.</citation>
    <PMID>16234497</PMID>
  </reference>
  <reference>
    <citation>Flum DR, Khan TV, Dellinger EP. Toward the rational and equitable use of bariatric surgery. JAMA. 2007 Sep 26;298(12):1442-4.</citation>
    <PMID>17895461</PMID>
  </reference>
  <reference>
    <citation>Meguid MM, Glade MJ, Middleton FA. Weight regain after Roux-en-Y: a significant 20% complication related to PYY. Nutrition. 2008 Sep;24(9):832-42. doi: 10.1016/j.nut.2008.06.027. Review.</citation>
    <PMID>18725080</PMID>
  </reference>
  <reference>
    <citation>Nguyen NT. Reoperations and revisions in bariatric surgery. Surg Endosc. 2007 Nov;21(11):1907-8. Epub 2007 Sep 8.</citation>
    <PMID>17828427</PMID>
  </reference>
  <reference>
    <citation>Sapala JA, Wood MH, Sapala MA, Flake TM Jr. Marginal ulcer after gastric bypass: a prospective 3-year study of 173 patients. Obes Surg. 1998 Oct;8(5):505-16.</citation>
    <PMID>9819081</PMID>
  </reference>
  <reference>
    <citation>Higa KD, Boone KB, Ho T. Complications of the laparoscopic Roux-en-Y gastric bypass: 1,040 patients--what have we learned? Obes Surg. 2000 Dec;10(6):509-13.</citation>
    <PMID>11175957</PMID>
  </reference>
  <reference>
    <citation>Sanyal AJ, Sugerman HJ, Kellum JM, Engle KM, Wolfe L. Stomal complications of gastric bypass: incidence and outcome of therapy. Am J Gastroenterol. 1992 Sep;87(9):1165-9.</citation>
    <PMID>1519574</PMID>
  </reference>
  <reference>
    <citation>Capella JF, Capella RF. Staple Disruption and Marginal Ulceration in Gastric Bypass Procedures for Weight Reduction. Obes Surg. 1996 Feb;6(1):44-49.</citation>
    <PMID>10731249</PMID>
  </reference>
  <reference>
    <citation>Capella JF, Capella RF. Gastro-gastric fistulas and marginal ulcers in gastric bypass procedures for weight reduction. Obes Surg. 1999 Feb;9(1):22-7; discussion 28.</citation>
    <PMID>10065576</PMID>
  </reference>
  <reference>
    <citation>Jordan JH, Hocking MP, Rout WR, Woodward ER. Marginal ulcer following gastric bypass for morbid obesity. Am Surg. 1991 May;57(5):286-8.</citation>
    <PMID>2039124</PMID>
  </reference>
  <reference>
    <citation>Sacks BC, Mattar SG, Qureshi FG, Eid GM, Collins JL, Barinas-Mitchell EJ, Schauer PR, Ramanathan RC. Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006 Jan-Feb;2(1):11-6.</citation>
    <PMID>16925306</PMID>
  </reference>
  <reference>
    <citation>Lublin M, McCoy M, Waldrep DJ. Perforating marginal ulcers after laparoscopic gastric bypass. Surg Endosc. 2006 Jan;20(1):51-4. Epub 2005 Dec 7.</citation>
    <PMID>16333541</PMID>
  </reference>
  <reference>
    <citation>St Jean MR, Dunkle-Blatter SE, Petrick AT. Laparoscopic management of perforated marginal ulcer after laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006 Nov-Dec;2(6):668.</citation>
    <PMID>17138240</PMID>
  </reference>
  <reference>
    <citation>Chin EH, Hazzan D, Sarpel U, Herron DM. Multimedia article. Laparoscopic repair of a perforated marginal ulcer 2 years after gastric bypass. Surg Endosc. 2007 Nov;21(11):2110. Epub 2007 Aug 18.</citation>
    <PMID>17704879</PMID>
  </reference>
  <reference>
    <citation>Wheeler AA, Matz ST, Fearing NM et al. Laparoscopic repair of perforated marginal ulcer following laparoscopic Roux-en-Y gastric bypass: a case series. Surg Endosc 2008; 22: S198 (Abstract).</citation>
  </reference>
  <reference>
    <citation>Nguyen NT, Hinojosa MW, Gray J, Fayad C. Reoperation for marginal ulceration. Surg Endosc. 2007 Nov;21(11):1919-21. Epub 2007 Aug 19. Review.</citation>
    <PMID>17705072</PMID>
  </reference>
  <reference>
    <citation>Patel RA, Brolin RE, Gandhi A. Revisional operations for marginal ulcer after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2009 May-Jun;5(3):317-22. doi: 10.1016/j.soard.2008.10.011. Epub 2008 Nov 6.</citation>
    <PMID>19136312</PMID>
  </reference>
  <reference>
    <citation>Hata JA, DeMaria EJ, Portenier DD et al. Marginal ulcer after 1,792 laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: incidence, medical and surgical treatment and complications. Surg Obes Relat Dis 2008; 4(3):308-9 (Abstract).</citation>
  </reference>
  <reference>
    <citation>Madan AK, DeArmond G, Ternovits CA, Beech DJ, Tichansky DS. Laparoscopic revision of the gastrojejunostomy for recurrent bleeding ulcers after past open revision gastric bypass. Obes Surg. 2006 Dec;16(12):1662-8.</citation>
    <PMID>17217644</PMID>
  </reference>
  <reference>
    <citation>Nguyen NT, Longoria M, Chalifoux S, Wilson SE. Gastrointestinal hemorrhage after laparoscopic gastric bypass. Obes Surg. 2004 Nov-Dec;14(10):1308-12.</citation>
    <PMID>15603643</PMID>
  </reference>
  <reference>
    <citation>Nguyen NT, Hinojosa MW, Gray J et al. (2008). Gastrointestinal bleeding after Roux-en-Y gastric bypass. In Weight loss surgery: A multidisciplinary approach (pp. 401-4). Edgemont, PA: Matrix Medical Communications.</citation>
  </reference>
  <reference>
    <citation>Braley SC, Nguyen NT, Wolfe BM. Late gastrointestinal hemorrhage after gastric bypass. Obes Surg. 2002 Jun;12(3):404-7.</citation>
    <PMID>12082897</PMID>
  </reference>
  <reference>
    <citation>Gutthann SP, García Rodríguez LA, Raiford DS. Individual nonsteroidal antiinflammatory drugs and other risk factors for upper gastrointestinal bleeding and perforation. Epidemiology. 1997 Jan;8(1):18-24.</citation>
    <PMID>9116088</PMID>
  </reference>
  <reference>
    <citation>Gralnek IM, Barkun AN, Bardou M. Management of acute bleeding from a peptic ulcer. N Engl J Med. 2008 Aug 28;359(9):928-37. doi: 10.1056/NEJMra0706113. Review.</citation>
    <PMID>18753649</PMID>
  </reference>
  <reference>
    <citation>Barkun AN. Should every patient with suspected upper GI bleeding receive a proton pump inhibitor while awaiting endoscopy? Gastrointest Endosc. 2008 Jun;67(7):1064-6. doi: 10.1016/j.gie.2008.02.040.</citation>
    <PMID>18513549</PMID>
  </reference>
  <reference>
    <citation>Fernández-Esparrach G, Bordas JM, Pellisé M, Gimeno-García AZ, Lacy A, Delgado S, Cárdenas A, Ginès A, Sendino O, Momblán D, Zabalza M, Llach J. Endoscopic management of early GI hemorrhage after laparoscopic gastric bypass. Gastrointest Endosc. 2008 Mar;67(3):552-5. doi: 10.1016/j.gie.2007.10.024.</citation>
    <PMID>18294521</PMID>
  </reference>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2009</study_first_submitted>
  <study_first_submitted_qc>December 28, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2009</study_first_posted>
  <last_update_submitted>December 28, 2009</last_update_submitted>
  <last_update_submitted_qc>December 28, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Kelvin D Higa, MD; FACS; FASMBS; Professor of Surgery, University of California San Francisco</name_title>
    <organization>UCSF Fresno / ALSA Medical Group, Inc. Minimally Invasive Surgery Program</organization>
  </responsible_party>
  <keyword>complicated marginal ulcer</keyword>
  <keyword>complex marginal ulcer</keyword>
  <keyword>complication after gastric bypass</keyword>
  <keyword>gastrointestinal hemorrhage</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

